HYPERION DEFI, INC. Other Notes Payable, Noncurrent
HYPERION DEFI, INC. (HYPD) had Other Notes Payable, Noncurrent of $5.64 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:OtherLongTermNotesPayable · last filed 2026-08-13
- 2026-06-30: Other Notes Payable, Noncurrent $5.64M.
- 2026-03-31: Other Notes Payable, Noncurrent $6.97M.
- 2025-12-31: Other Notes Payable, Noncurrent $7.80M.
- 2025-09-30: Other Notes Payable, Noncurrent $7.66M.
| Period end | Other Notes Payable, Noncurrent |
|---|---|
| 2026-06-30 | $5.64M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.97M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.80M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $7.66M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $7.52M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $637.50K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $637.50K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.10M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $4.36M 10-K · filed 2025-04-15 |
| 2023-09-30 | $6.55M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.68M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.73M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $4.19M 10-K · filed 2024-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |